A. Beeler

In vitro tests of T cell-mediated drug hypersensitivity

W. Pichler, A. Beeler, 2006, Expert review of clinical immunology.

CD69 upregulation on T cells as an in vitro marker for delayed‐type drug hypersensitivity

W. Pichler, A. Beeler, L. Zaccaria, 2007, Allergy.

Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions.

W. Pichler, A. Beeler, B. Gerber, 2006, The Journal of allergy and clinical immunology.

Drug‐specific in vitro release of IL‐2, IL‐5, IL‐13 and IFN‐γ in patients with delayed‐type drug hypersensitivity

W. Pichler, A. Beeler, T. Kawabata, 2009, Allergy.

Cross-reactivity patterns of T cells specific for iodinated contrast media.

M. Britschgi, W. Pichler, A. Bircher, 2007, The Journal of allergy and clinical immunology.

Cross-Reactivity in Drug Hypersensitivity Reactions to Sulfasalazine and Sulfamethoxazole

W. Pichler, A. Beeler, A. Zawodniak, 2010, International Archives of Allergy and Immunology.

Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study.

C. Gobbi, C. Zecca, K. Přikrylová, 2019, Multiple sclerosis and related disorders.

Pharmacological interaction of drugs with immune receptors: the p-i concept.

W. Pichler, M. Keller, A. Beeler, 2006, Allergology international : official journal of the Japanese Society of Allergology.

SwissTecLive: effectiveness and safety of dimethyl fumarate in the treatment of RRMS in the Swiss clinical practice setting

C. Gobbi, C. Zecca, A. Beeler, 2020, Heliyon.

Drug‐specific in vitro release of IL‐2, IL‐5, IL‐13 and IFN‐γ in patients with delayed‐type drug hypersensitivity

A. Beeler, Priska Lochmatter, W. J. Pichler, 2009, Allergy.